In line with its cardinal role in immune control of M. tuberculosis infection, CXCL10 has emerged as a potential correlate for treatment efficacy as well as a measure of TB disease severity and correlate of risk (14–19). The gene discussed is CXCL10; the disease is tuberculosis.